
Neeraj Sharma
Examiner (ID: 5222, Phone: (571)270-5487 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2626 |
| Total Applications | 582 |
| Issued Applications | 475 |
| Pending Applications | 51 |
| Abandoned Applications | 71 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7651280
[patent_doc_number] => 20110300549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'Treatment of Development-Related Disorders'
[patent_app_type] => utility
[patent_app_number] => 13/206003
[patent_app_country] => US
[patent_app_date] => 2011-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18821
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20110300549.pdf
[firstpage_image] =>[orig_patent_app_number] => 13206003
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/206003 | Treatment of Development-Related Disorders | Aug 8, 2011 | Abandoned |
Array
(
[id] => 11343504
[patent_doc_number] => 09527899
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'Recombinant human follicle-stimulating hormone'
[patent_app_type] => utility
[patent_app_number] => 13/814059
[patent_app_country] => US
[patent_app_date] => 2011-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15492
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814059
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/814059 | Recombinant human follicle-stimulating hormone | Aug 3, 2011 | Issued |
Array
(
[id] => 9016315
[patent_doc_number] => 20130231279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'OXYTOCIN TREATMENT TO IMPROVE MEMORY AND MODIFY BLOOD GLUCOSE'
[patent_app_type] => utility
[patent_app_number] => 13/812850
[patent_app_country] => US
[patent_app_date] => 2011-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12530
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812850
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/812850 | Intranasal oxytocin treatment to improve schizophrenia | Jul 29, 2011 | Issued |
Array
(
[id] => 7767855
[patent_doc_number] => 20120035109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'FOLLICLE STIMULATING HORMONE SUPERAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/187956
[patent_app_country] => US
[patent_app_date] => 2011-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 16628
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20120035109.pdf
[firstpage_image] =>[orig_patent_app_number] => 13187956
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/187956 | Follicle stimulating hormone superagonists | Jul 20, 2011 | Issued |
Array
(
[id] => 7710111
[patent_doc_number] => 20120003180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'PERLECAN DOMAIN V PROTECTS, REPAIRS AND RESTORES ISCHEMIC BRAIN STROKE INJURY AND MOTOR FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 13/175518
[patent_app_country] => US
[patent_app_date] => 2011-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 33900
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13175518
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/175518 | Perlecan domain V protects, repairs and restores ischemic brain stroke injury and motor function | Jun 30, 2011 | Issued |
Array
(
[id] => 9843913
[patent_doc_number] => 08945828
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-03
[patent_title] => 'Method of identifying fetal antigens or cell surface markers using phage display technology'
[patent_app_type] => utility
[patent_app_number] => 13/169922
[patent_app_country] => US
[patent_app_date] => 2011-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20815
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13169922
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/169922 | Method of identifying fetal antigens or cell surface markers using phage display technology | Jun 26, 2011 | Issued |
Array
(
[id] => 7509859
[patent_doc_number] => 20110256097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'Treatment of Conditions that Increase in Severity and/or Occurrence During One or More Phases of the Menstrual Cycle'
[patent_app_type] => utility
[patent_app_number] => 13/169897
[patent_app_country] => US
[patent_app_date] => 2011-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31685
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20110256097.pdf
[firstpage_image] =>[orig_patent_app_number] => 13169897
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/169897 | Treatment of Conditions that Increase in Severity and/or Occurrence During One or More Phases of the Menstrual Cycle | Jun 26, 2011 | Abandoned |
Array
(
[id] => 9041205
[patent_doc_number] => 20130243843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'Vitronectin:Keratinocyte Growth Factor Chimeras'
[patent_app_type] => utility
[patent_app_number] => 13/701472
[patent_app_country] => US
[patent_app_date] => 2011-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9867
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701472
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/701472 | Vitronectin:keratinocyte growth factor chimeras | Jun 2, 2011 | Issued |
Array
(
[id] => 7744258
[patent_doc_number] => 20120021984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'Glycoprotein Hormone Analogs'
[patent_app_type] => utility
[patent_app_number] => 13/114861
[patent_app_country] => US
[patent_app_date] => 2011-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 26577
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20120021984.pdf
[firstpage_image] =>[orig_patent_app_number] => 13114861
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/114861 | Salmon follitropin hormone analogs | May 23, 2011 | Issued |
Array
(
[id] => 7499261
[patent_doc_number] => 20110262390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'COMPOSITION AND METHOD FOR TREATING INFLAMMATORY DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/113552
[patent_app_country] => US
[patent_app_date] => 2011-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 25946
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20110262390.pdf
[firstpage_image] =>[orig_patent_app_number] => 13113552
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/113552 | COMPOSITION AND METHOD FOR TREATING INFLAMMATORY DISORDERS | May 22, 2011 | Abandoned |
Array
(
[id] => 8815132
[patent_doc_number] => 20130116177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'USE OF AROMATASE INHIBITORS FOR SYNCHRONIZING OVULATION, INDUCING SUPEROVULATION OR DOUBLE OVULATION AND IMPROVING TWINNING AND FERTILITY IN A MAMMAL'
[patent_app_type] => utility
[patent_app_number] => 13/698402
[patent_app_country] => US
[patent_app_date] => 2011-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 18484
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698402
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/698402 | Methods of administering an aromatase inhibitor, prostaglandin and GnRH for regulating ovulation in cattle | May 18, 2011 | Issued |
Array
(
[id] => 6090353
[patent_doc_number] => 20110218147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'ACTIVIN-ACTRIIA ANTAGONISTS FOR INHIBITING GERM CELL MATURATION'
[patent_app_type] => utility
[patent_app_number] => 13/111393
[patent_app_country] => US
[patent_app_date] => 2011-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 23004
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20110218147.pdf
[firstpage_image] =>[orig_patent_app_number] => 13111393
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/111393 | Activin-actriia antagonists for inhibiting germ cell maturation | May 18, 2011 | Issued |
Array
(
[id] => 8928414
[patent_doc_number] => 20130184174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'DETECTION METHOD FOR 305 FERTILITY-ASSOCIATED SPERM LOCALIZATION PROTEINS EX-PRESSED IN HUMAN TESTIS AND EPIDIDYMIS'
[patent_app_type] => utility
[patent_app_number] => 13/700218
[patent_app_country] => US
[patent_app_date] => 2011-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10099
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13700218
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/700218 | Detection method for 305 fertility-associated sperm localization proteins expressed in human testis and epididymis | May 17, 2011 | Issued |
Array
(
[id] => 8062889
[patent_doc_number] => 20110245592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'Secretome Profile-Facilitated In Vitro Fertilization'
[patent_app_type] => utility
[patent_app_number] => 13/081463
[patent_app_country] => US
[patent_app_date] => 2011-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9392
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20110245592.pdf
[firstpage_image] =>[orig_patent_app_number] => 13081463
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/081463 | Secretome Profile-Facilitated In Vitro Fertilization | Apr 5, 2011 | Abandoned |
Array
(
[id] => 6177399
[patent_doc_number] => 20110178012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'USE OF HUMAN CHORIONIC GONADOTROPIN ORALLY FOR THE TREATMENT OF OVERWEIGHT (OBESITY) ASSOCIATED WITH HIGH BLOOD TENSION, NON-INSULIN-DEPENDANT DIABETES, HYPERCHOLESTEROLEMIA, DYSLIPIDEMIAS AND LIPODYSTROPHY.'
[patent_app_type] => utility
[patent_app_number] => 13/078474
[patent_app_country] => US
[patent_app_date] => 2011-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 460
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20110178012.pdf
[firstpage_image] =>[orig_patent_app_number] => 13078474
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/078474 | USE OF HUMAN CHORIONIC GONADOTROPIN ORALLY FOR THE TREATMENT OF OVERWEIGHT (OBESITY) ASSOCIATED WITH HIGH BLOOD TENSION, NON-INSULIN-DEPENDANT DIABETES, HYPERCHOLESTEROLEMIA, DYSLIPIDEMIAS AND LIPODYSTROPHY. | Mar 31, 2011 | Abandoned |
Array
(
[id] => 7587242
[patent_doc_number] => 20110281752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'BETA-SECRETASE ENZYME COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/070413
[patent_app_country] => US
[patent_app_date] => 2011-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 31378
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281752.pdf
[firstpage_image] =>[orig_patent_app_number] => 13070413
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/070413 | BETA-SECRETASE ENZYME COMPOSITIONS AND METHODS | Mar 22, 2011 | Abandoned |
Array
(
[id] => 7490155
[patent_doc_number] => 20110237523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'CONTRACEPTIVE PEPTIDES DERIVED FROM THE VENOM OF THE SPIDER Latrodectus mirabilis, NUCLEOTIDE SEQUENCES TO TRANSFORM A MICROORGANISM TO PRODUCE SAID PEPTIDES; METHODS TO OBTAIN THE PEPTIDES; PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/053751
[patent_app_country] => US
[patent_app_date] => 2011-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4227
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237523.pdf
[firstpage_image] =>[orig_patent_app_number] => 13053751
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/053751 | Contraceptive peptides derived from the venom of the spider Latrodectus mirabilis, nucleotide sequences to transform a microorganism to produce said peptides; methods to obtain the peptides; pharmaceutical compositions containing thereof and use thereof | Mar 21, 2011 | Issued |
Array
(
[id] => 8417603
[patent_doc_number] => 20120245104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'NOVEL RETRO-INVERSO LEPTIN PEPTIDE ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/053636
[patent_app_country] => US
[patent_app_date] => 2011-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14901
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13053636
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/053636 | NOVEL RETRO-INVERSO LEPTIN PEPTIDE ANTAGONISTS | Mar 21, 2011 | Abandoned |
Array
(
[id] => 9026542
[patent_doc_number] => 08536124
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-17
[patent_title] => 'Artificial decapeptide for inducing vitellogenesis in fish'
[patent_app_type] => utility
[patent_app_number] => 13/050485
[patent_app_country] => US
[patent_app_date] => 2011-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2677
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13050485
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/050485 | Artificial decapeptide for inducing vitellogenesis in fish | Mar 16, 2011 | Issued |
Array
(
[id] => 8566128
[patent_doc_number] => 20120328699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-27
[patent_title] => 'METHOD AND COMPOSITION FOR TREATMENT OF SKELETAL DYSPLASIAS'
[patent_app_type] => utility
[patent_app_number] => 13/006129
[patent_app_country] => US
[patent_app_date] => 2011-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11001
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13006129
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/006129 | METHOD AND COMPOSITION FOR TREATMENT OF SKELETAL DYSPLASIAS | Jan 12, 2011 | Abandoned |